+0049 1511 477 48-56

Anticancer Products

Venus Pharma GmbH is committed to the fight against cancer through itsadvanced range of Anticancer Injectables. Our products are designed to provide effective treatment options that address the unique needsof cancer patients. With a focus on precision, safety, and innovation, our injectables are developed using state-of-the-art technologies and rigorous quality standards. We aim to enhance patient outcomes and improve quality of life through therapies that target cancer at its core while minimizing adverse effects.

Venus Pharmaceuticals Germany

Products

Product Portfolio for Regulated Markets.

Azacitidine
100 mg
Bendamustine
100 mg
Bleomycin
15000 IU
Carboplatin
150MG/15ML, 450MG/45ML
Docetaxel
20 MG/0.5 ML, 80 MG/2 ML, 120 MG/3 ML, 20 MG/1 ML, 80 MG/4 ML, 160 MG/8 ML
Irinotecan
40 MG/2 ML, 100 MG/5 ML
Paclitaxel
30 MG/5 ML, 100 MG/16.7 ML, 150 MG/25 ML, 300 MG/50 ML
Plerixafor
24 MG/1.2 ML

Pioneering Global Excellence with Cutting-Edge Pharmaceutical Solutions

Leveraging the resourceful pool of skilled workforce & state-of-the-art technologies, Venus products are entering the bucket of the best pharmaceutical products globally. Our pharmaceutical products comprise both generic and research-based solutions that aim to meet unmet medical needs.

Injectable Pharmaceuticals